Deerfield Management as of Sept. 30, 2016
Portfolio Holdings for Deerfield Management
Deerfield Management holds 90 positions in its portfolio as reported in the September 2016 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Gw Pharmaceuticals Plc ads | 6.2 | $134M | 1.0M | 132.73 | |
Portola Pharmaceuticals | 6.0 | $128M | 5.6M | 22.71 | |
Horizon Pharma | 5.4 | $117M | 6.4M | 18.13 | |
NxStage Medical | 4.8 | $102M | 4.1M | 24.99 | |
Avexis | 4.3 | $92M | 2.2M | 41.21 | |
Horizon Pharma Plc convertible security | 3.7 | $80M | 83M | 0.97 | |
Healthways Inc note 1.500% 7/0 | 3.7 | $79M | 54M | 1.46 | |
Adeptus Health Inc-class A | 3.2 | $69M | 1.6M | 43.05 | |
Dbv Technologies S A | 3.0 | $63M | 1.7M | 36.33 | |
Vanda Pharmaceuticals (VNDA) | 2.7 | $57M | 3.4M | 16.64 | |
Nevro (NVRO) | 2.6 | $56M | 536k | 104.39 | |
Xencor (XNCR) | 2.5 | $54M | 2.2M | 24.49 | |
Mylan Nv | 2.5 | $54M | 1.4M | 38.12 | |
Array Biopharma Inc note 3.000% 6/0 | 2.5 | $53M | 45M | 1.18 | |
Flamel Technologies | 2.4 | $51M | 4.1M | 12.40 | |
Aerie Pharmaceuticals | 2.4 | $51M | 1.3M | 37.74 | |
Trn 4% 04/01/45 | 2.2 | $47M | 48M | 0.97 | |
Wright Med Group Inc note 2.000% 2/1 | 2.0 | $43M | 40M | 1.07 | |
Aetna | 2.0 | $42M | 366k | 115.45 | |
Endologix Inc note 2.250%12/1 | 1.8 | $39M | 41M | 0.96 | |
Aac Holdings | 1.8 | $38M | 2.2M | 17.39 | |
Universal American | 1.6 | $35M | 4.6M | 7.65 | |
Nivalis Therapeutics | 1.4 | $30M | 3.7M | 8.13 | |
eHealth (EHTH) | 1.4 | $30M | 2.6M | 11.21 | |
Walgreen Boots Alliance (WBA) | 1.3 | $29M | 356k | 80.62 | |
Humana (HUM) | 1.3 | $28M | 160k | 176.89 | |
Galapagos Nv- (GLPG) | 1.3 | $27M | 423k | 64.66 | |
Syros Pharmaceuticals | 1.2 | $25M | 1.8M | 13.87 | |
Audentes Therapeutics | 1.2 | $25M | 1.4M | 17.81 | |
Tesaro | 1.1 | $24M | 242k | 100.24 | |
DaVita (DVA) | 1.1 | $23M | 350k | 66.07 | |
Editas Medicine (EDIT) | 1.1 | $23M | 1.7M | 13.48 | |
Spark Therapeutics | 1.0 | $22M | 368k | 60.06 | |
BioCryst Pharmaceuticals (BCRX) | 0.9 | $19M | 4.4M | 4.41 | |
Glaukos (GKOS) | 0.9 | $19M | 503k | 37.74 | |
Select Medical Holdings Corporation (SEM) | 0.8 | $18M | 1.4M | 13.50 | |
Invuity | 0.8 | $18M | 1.3M | 13.72 | |
Axogen (AXGN) | 0.8 | $17M | 1.9M | 9.03 | |
Fluidigm Corporation convertible cor | 0.8 | $17M | 28M | 0.61 | |
Five Prime Therapeutics | 0.8 | $16M | 311k | 52.49 | |
Bluebird Bio (BLUE) | 0.7 | $15M | 224k | 67.78 | |
Cytomx Therapeutics (CTMX) | 0.7 | $15M | 943k | 15.68 | |
Proteon Therapeutics | 0.7 | $15M | 1.6M | 9.33 | |
Foamix Pharmaceuticals | 0.6 | $12M | 1.3M | 9.26 | |
Array BioPharma | 0.5 | $11M | 1.7M | 6.75 | |
Akari Therapeutics | 0.5 | $9.8M | 1.2M | 8.51 | |
Alimera Sciences | 0.4 | $8.8M | 5.9M | 1.49 | |
Myokardia | 0.4 | $8.2M | 500k | 16.34 | |
St. Jude Medical | 0.4 | $8.0M | 100k | 79.76 | |
Ardelyx (ARDX) | 0.4 | $8.0M | 619k | 12.94 | |
Axovant Sciences | 0.4 | $8.0M | 568k | 14.00 | |
Aralez Pharmaceuticals | 0.4 | $8.0M | 1.6M | 4.85 | |
EXACT Sciences Corporation (EXAS) | 0.3 | $6.6M | 358k | 18.57 | |
Loxo Oncology | 0.3 | $6.6M | 251k | 26.18 | |
Blueprint Medicines (BPMC) | 0.3 | $6.4M | 216k | 29.70 | |
Steadymed | 0.3 | $6.3M | 1.8M | 3.59 | |
Oxford Immunotec Global | 0.3 | $5.8M | 465k | 12.56 | |
Essa Pharma | 0.3 | $5.8M | 2.1M | 2.75 | |
BioScrip | 0.3 | $5.7M | 2.0M | 2.89 | |
CAS Medical Systems | 0.3 | $5.5M | 3.2M | 1.73 | |
Kempharm | 0.2 | $4.9M | 1.1M | 4.49 | |
pSivida | 0.2 | $4.5M | 1.5M | 3.01 | |
Nanostring Technologies (NSTGQ) | 0.2 | $4.5M | 227k | 19.98 | |
Catabasis Pharmaceuticals | 0.2 | $4.2M | 683k | 6.16 | |
Scynexis | 0.2 | $4.1M | 1.0M | 3.87 | |
Global Blood Therapeutics In | 0.2 | $4.0M | 171k | 23.05 | |
Molina Healthcare Inc conv | 0.2 | $3.6M | 3.0M | 1.19 | |
Acorda Therapeutics | 0.2 | $3.4M | 162k | 20.88 | |
Genocea Biosciences | 0.2 | $3.5M | 687k | 5.12 | |
Exelixis (EXEL) | 0.1 | $3.2M | 247k | 12.79 | |
Infinity Pharmaceuticals (INFIQ) | 0.1 | $3.0M | 1.9M | 1.56 | |
Aclaris Therapeutics (ACRS) | 0.1 | $3.0M | 116k | 25.61 | |
Epizyme | 0.1 | $2.9M | 291k | 9.84 | |
Voyager Therapeutics (VYGR) | 0.1 | $2.8M | 235k | 12.01 | |
Proteostasis Therapeutics In | 0.1 | $2.9M | 186k | 15.59 | |
Trillium Therapeutics, Inc. Cmn | 0.1 | $2.5M | 172k | 14.78 | |
Pronai Therapeutics | 0.1 | $2.5M | 1.4M | 1.82 | |
Rite Aid Corporation | 0.1 | $2.1M | 275k | 7.69 | |
Healthways | 0.1 | $2.0M | 76k | 26.46 | |
Agile Therapeutics | 0.1 | $1.7M | 250k | 6.98 | |
Acura Pharmaceuticals (ACUR) | 0.1 | $1.6M | 1.0M | 1.60 | |
Threshold Pharmaceuticals | 0.1 | $1.5M | 2.2M | 0.68 | |
Ocera Therapeutics | 0.1 | $1.5M | 573k | 2.64 | |
Neos Therapeutics | 0.1 | $1.5M | 229k | 6.58 | |
BioMarin Pharmaceutical (BMRN) | 0.1 | $1.3M | 14k | 92.54 | |
Regeneron Pharmaceuticals (REGN) | 0.1 | $1.3M | 3.3k | 402.12 | |
Teva Pharmaceutical Industries (TEVA) | 0.1 | $1.4M | 30k | 46.00 | |
Streamline Health Solutions | 0.1 | $1.2M | 663k | 1.84 | |
Paratek Pharmaceuticals | 0.1 | $1.3M | 100k | 13.01 | |
Clovis Oncology | 0.0 | $288k | 8.0k | 36.00 |